Penserra Capital Management’s Akso Health Group AHG Stock Holding History

Penserra Capital Management’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,146	Closed	-$2K	–	1336
2021 Q1	$2K	Buy	1,146 +764	+200%	+$1.72K	﹤0.01%	1100
2020 Q4	$0	Sell	382 -534	-58%	-$1.18K	﹤0.01%	1007
2020 Q3	$1K	Sell	916 -1,439	-61%	-$3.2K	﹤0.01%	919
2020 Q2	$5K	Hold	2,355	–	–	﹤0.01%	784
2020 Q1	$2K	Buy	2,355 +394	+20%	+$600	﹤0.01%	831
2019 Q4	$3K	Sell	1,961 -204	-9%	-$535	﹤0.01%	857
2019 Q3	$9K	Sell	2,165 -303	-12%	-$1.9K	﹤0.01%	799
2019 Q2	$17K	Buy	+2,468	New	+$20.6K	﹤0.01%	768

Other funds holding AHG

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Penserra Capital Management's AHG Position: Q2 2021 in Review

Penserra Capital Management sold out of Akso Health Group (AHG) in Q2 2021, closing a stake of 1,146 shares — an estimated $2K sold.

Penserra Capital Management first reported a position in AHG in Q2 2019 and held it in 8 quarters. The position peaked at $17K in Q2 2019. 3 funds tracked by Wall St. Rank hold AHG as of Q2 2021.

Penserra Capital Management reported no remaining Akso Health Group position as of Q2 2021 after selling out during the quarter.
Penserra Capital Management sold 1,146 Akso Health Group shares in Q2 2021, an estimated $2K.
Penserra Capital Management first reported a position in Akso Health Group in Q2 2019 and held it in 8 quarters.
Penserra Capital Management's Akso Health Group position peaked at $17K in Q2 2019.
3 funds tracked by Wall St. Rank held Akso Health Group as of Q2 2021.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.